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Purpose: According to previous studies, the prevalence of premature ejaculation (PE) in Korea ranges from 11.3% to 33%. 
However, the actual practice patterns in managing patients with PE is not well known. In this study, we have endeavored to 
determine how contemporary urologists in Korea manage patients with PE.
Materials and Methods: The e-mailing list was obtained from the Korean Urological Association Registry of Physicians. A 
specifically designed questionnaire was e-mailed to the 2,421 urologists in Korea from May 2012 to August 2012. 
Results: Urologists in Korea diagnosed PE using various criteria: the definition of the International Society for Sexual Medicine 
(63.4%), Diagnostic and Statistical Manual of Mental Disorders (43.8%), International Statistical Classification of Disease, 10th 
edition (61.7%), or perceptional self-diagnosis by the patient himself (23.5%). A brief self-administered questionnaire, the 
Premature Ejaculation Diagnostic Tool, was used by only 42.5% of the urologists. Selective-serotonin reuptake inhibitor (SSRI) 
therapy was the main treatment modality (91.5%) for PE patients. 40.2% of the urologists used phosphodiesterase type 5 
inhibitors, 47.6% behavior therapy, and 53.7% local anesthetics. Further, 286 (54.3%) urologists managed PE patients with a 
surgical modality such as selective dorsal neurotomy (SDN).
Conclusions: A majority of Korean urologists diagnose PE by a multidimensional approach using various diagnostic tools. Most 
urologists believe that medical treatment with an SSRI is effective in the management of PE. At the same time, surgical treatment 
such as SDN also investigated as one of major treatment modality despite the lack of scientific evidence.
Key Words: Physician’s practice patterns; Premature ejaculation; Urologic surgical procedures 
INTRODUCTION
　Premature ejaculation (PE) is one of the most common 
sexual dysfunctions in male patients. Previous studies have 
reported that approximately 30% of adult men suffer from 
PE [1-3]. In spite of the increasing interest in PE in the field 
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of sexual medicine, our knowledge about the prevalence, 
etiology, diagnosis, and treatment of PE is scarce. Thus far, 
multiple factors such as neurobiological cascades related 
to the metabolism of neurotransmitters, hyperthyroidism, 
psychological problems, critical life experiences, and pen-
ile hypersensitivity are commonly accepted as the etiology 
of PE. Because of these multiple etiologies of PE, a unified 
definition of PE has not been established. Currently, the 
major components of the diagnosis of PE are short intra-
vaginal ejaculatory latency time (IELT), inability to delay 
ejaculation, and personal distress [4,5]. 
　There are many treatment options for patients with PE, 
such as psychological education, selective-serotonin reup-
take inhibitors (SSRIs), phosphodiesterase type 5 (PDE5) in-
hibitors, topical anesthetics, selective dorsal neurotomy 
(SDN), and hyaluronic acid gel glans penis augmentation 
[6-8]. The preferred management of PE is an on-demand 
SSRI or daily SSRI. Shindel et al [9] reported that 71% of the 
urologists in the United States prescribed an SSRI as the ini-
tial management of PE. However, many urologists used 
other treatment options in 35% of the initial treatment cas-
es and 50% of the second-line treatment cases.
　Previous studies showed that the prevalence of PE in 
Korea is between 11.3% and 33% [3,10,11]. However, 
the daily practice patterns of urologists in the management 
of patients with PE have not been studied. In this study, we 
conducted an e-mail-based survey to analyze the practice 
patterns of Korean urologists in their management of pa-
tients with PE.
MATERIALS AND METHODS 
　After the Institutional Review Board approval was ob-
tained from our hospital, the e-mailing list was retrieved 
from the Korean Urological Association Registry of 
Physicians. A specifically designed questionnaire was 
e-mailed to the 2,421 urologists in Korea from May 2012 
to August 2012. Second and third e-mails were sent to 
non-responders at one and two months after the first 
e-mail. The questionnaire consisted of five questions 
about responder demographics, eleven questions about 
the management of PE, and ten questions about SDN. The 
survey explored practice characteristics and attitudes, as 
well as diagnosis and treatment patterns, for the manage-
ment of PE. There was no compensation provided for 
participation.
RESULTS
　Replies were received from 527 (21.8%) practicing 
urologists. Two hundreds and ninety (55%) were private 
clinicians. One hundred and fifty-eight (30%) and 79 urol-
ogists (15%) worked at teaching hospitals and non-teach-
ing hospitals, respectively. The mean age was 43.2 
(interquartile range [IQR]: 37 to 50) years. The mean peri-
od after acquiring board certification was 12.3 (IQR: 5 to 
12) years (Table 1).
　Approximately half of the urologists (232, 44%) had 
treated less than two PE patients per week for the past three 
months. One hundred and sixty-five (31.3%) urologists 
treated three to five PE patients. Seventy-eight (14.8%) 
treated six to ten PE patients. Fifty (9.5%) treated more 
than eleven PE patients a week. A multiple-choice ques-
tion revealed that urologists in Korea based their diagnosis 
of PE most commonly on the definition by International 
Society for Sexual Medicine (ISSM, 63.4%), Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV-TR, 
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Table 2. Complications after selective dorsal neurotomy
Complication Experience of surgeon (%) Total 44,000 cases (%)
Recurrence of premature ejaculation 





























Fig. 1. Korean urologist practice pattern for treatment of premature
ejaculation. SSRIs: selective-serotonin reuptake inhibitors, SDN: 
selective dorsal neurotomy, PDE5i: phosphodiesterase 5 inhi-
bitor, TCA: tricyclic antidepressant, HA: hyaluronic acid.
Fig. 2. Preference of selective-serotonin reuptake inhibitors in 
Korean urologists.
43.8%), International Statistical Classification of Disease, 
10th edition (ICD-10, 61.7%), and self-diagnosis by the 
patient alone (23.5%) in descending order. Only 42.5% of 
the urologists used the Premature Ejaculation Diagnostic 
Tool, a brief self-administered questionnaire provided to 
patients. Diagnosis based on IELT was varied, with 157 
(29.8%) considering less than 1 minute as the appropriate 
criteria, while 22.2% believed that less than 2 minutes 
was appropriate. Furthermore, 20.7% based their diag-
nosis on subjective symptoms, irrespective of IELT. 
　Urologists in Korea treated PE patients with multiple mo-
dalities (Fig. 1). SSRI was considered the primary treat-
ment of choice. SSRIs were used by 91.5% of the urolo-
gists, and dapoxetine was the most frequently prescribed 
medication (87.3%) followed by the off-label use of sertra-
line (29.7%), fluoxetine (19.7%), and paroxetine (11.6%) 
(Fig. 2). PED5 inhibitors were used by 40.2% of the urolo-
gists, and behavioral therapy was used by 47.6% for PE 
patients. The urologists of 53.7% used local anesthetics. 
Further, some urologists managed PE patients with surgi-
cal modalities such as SDN (286, 54.3%) and hyaluronic 
acid gel glans or autologous fat glans augmentation (89, 
16.9%). 
　Three hundreds and eighty-four (72.9%) urologists in 
Korea had prior experience of SDN. Almost all private 
clinicians (272, 93.5%) reported that they were capable of 
performing SDN. Half of the hospital-based urologists re-
ported a prior experience of performing SDN (112, 
47.5%). Two hundreds and twelve (72.9%) private clini-
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cians, 31 (39.7%) non-teaching hospital urologists, and 48 
(30.0%) teaching hospital urologists thought that SDN 
was necessary for the management of PE patients. SDN 
was performed most commonly when patients themselves 
demanded surgical management. SDN was suggested to 
patients who benefitted from local anesthetics or who suf-
fered from penile hypersensitivity, as diagnosed by a pen-
ile vibration perception threshold test. The urologists be-
lieved that 57% patients were satisfied with SDN, 39.6% 
patients considered it ‘not bad,’ and only 3.4% patients 
were dissatisfied. 
　The most common complication of SDN was reported 
to be the recurrence of PE. Pain or paresthesia on the glans, 
and edema of the operation site followed (Table 2). Other 
than the abovementioned complications, hematoma, 
wound dehiscence, scar formation at the operation site, 
penile curvature, ejaculation dysfunction, erectile dys-
function, and psychotic disorder were noted by experi-
enced urologists. However, the rate of other complica-
tions was very low.
DISCUSSION
　Selective SSRIs had led the way to a new era of 
treatment. However, the understanding of PE is not yet 
complete. In fact, although an on-demand SSRI, a daily 
SSRI, or local anesthetics have been introduced for the 
treatment of PE, many patients continue to suffer from PE 
due to a lack of definite treatment.
　There are several proposed etiologies of PE. With regard 
to etiologies, PE can be classified largely into lifelong PE 
and acquired PE. Lifelong PE can be explained by either 
the hypersensitivity of the 5-HT1A receptor or the hypo-
sensitivity of 5-HT2C [12], and is considered to be related 
to genetic factors [13,14], biologic hypersensitivity, and 
hyperexcitability of the glans penis [15]. Erectile dysfunc-
tion, prostatitis, thyroid dysfunction, and psychological 
problems were also considered possible explanations of 
acquired PE [16-18].
　The diagnosis of PE consisted of three principles: short 
IELT, inability to delay ejaculation, and negative personal 
consequences. In DSM-IV-TR and ICD-10, the authors be-
lieved that distress or interpersonal difficulties and inabil-
ity to control ejaculation were important components of 
PE diagnosis along with short sexual intercourse time 
[5,19]. In ISSM 2008, a vaginal penetration time of within 
1 minute was proposed for the diagnosis of PE as the most 
important factor [4]. In this survey, 63.4% Korean urolo-
gists thought that ejaculation within 1 minute of vaginal 
penetration was the most important diagnostic criterion. 
However, interpersonal difficulties (43.8%) and ejacu-
lation before the patient and partner could enjoy a sexual 
interaction sufficiently (61.7%) were considered im-
portant as well. 23.5% of the urologists diagnosed PE if the 
patient thought he had PE. 
　SSRIs are very effective medications. An SSRI can be tak-
en on-demand or daily or in combination with some other 
medication. Daily medication with an SSRI showed a sig-
nificantly elongated stopwatch IELT. In prospective stud-
ies, a daily dose of paroxetine (20 mg) increased IELT by 
up to 783%; a daily dose of sertralin (50 mg), by up to 
313%; and a daily dose of fluoxetine (20 to 40 mg), by up 
to 295% [20]. An on-demand SSRI, dapoxetine, increased 
the stopwatch IELT from 0.9 minutes to approximately 3 
minutes [21]. In this survey, dapoxetine was the most fre-
quently prescribed medication. Although SSRIs are effec-
tive oral medications, they have a drawback that cannot 
be ignored. A previous study reported that 12.6% of the 
patients (6 of 48) dropped out from a 6-week daily SSRI tri-
al because of side effects [22]. The reported side effects 
were fatigue, drowsiness, nausea and vomiting, dry 
mouth, decreased libido, and ED [23].
　Korean urologists used local anesthetics in 53.7% of 
their cases for the management of PE, which is higher than 
the usage rate of urologists in the United States [9]. 
Lidocaine gel was the most common local anesthetic used 
(58.8%), followed by the Severance Secret cream (19.4%) 
and lidocaine-prilocaine cream (12.0%). There was an 
opinion that PE is related to penile hyposensitivity in ED 
patients [24]. However, many previous studies have re-
ported that penile sensitivity was related to ejaculatory la-
tency [25] and that penile hypersensitivity was related to 
PE [15]. Therefore, a blockage of the relationship between 
penile hypersensitivity and PE may improve the IELT time. 
Previous data showed that local anesthetics increased the 
stopwatch IELT by 5.6 to 7.8 times [26,27]. Local anes-
thetics did not have general side effects. However, local ir-
ritation, loss of penile sensation, and erectile dysfunction 
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were reported. Moreover, a local anesthetic was incon-
venient and messy to use and could interfere with arousal 
and spontaneity. Although it occurred in only a small 
number of cases, the loss of vaginal sensation with a fe-
male partner was reported. 
　According to the European Urology Guideline Form 
2010, the effectiveness of PDE5 inhibitors in the treatment 
of PE is associated with a 2B level of evidence and a grade 
C level of recommendation, which reflects that the use of 
these compounds in patients with PE and without ED is not 
yet fully established [23]. However, some of the recent da-
ta support the favorable effects of PDE5 inhibitors with re-
spect to the treatment of PE. According to the result of the 
first meta-analysis, the PDE5 inhibitor has an overall pos-
itive effect on the treatment of PE as monotherapy or as a 
component of a combination regimen when compared 
with SSRI monotherapy [28]. In this study, many of the par-
ticipating Korean urologists (40.2%) prescribed PDE5 in-
hibitors for the treatment of PE. 
　Thus far, across the world, surgical management of PE 
such as SDN has not been recommended for the treatment 
of PE because surgical management may induce perma-
nent loss of sexual function, and reliable data on SDN are 
insufficient [29]. However, SDN increased IELT from 1.1 
minutes to 3.8 minutes and improved ejaculation control 
[8]. Except post-operative wound pain, no other complica-
tion was noted. In PE patients who were treated by using 
computed tomography (CT)-guided cryoablation of the 
dorsal penile nerve, IELT increased from 54.7 seconds to 
182.5 seconds [30]. Four of the 24 patients developed in-
creased flaccidity and improved in time. Further, the glans 
gel injection was effective for PE patients with glans penis 
hypersensitivity [7]. In this survey, SDN was one of popu-
lar surgical procedures for private clinic urologists in 
Korea to selected patients who had an effect for local anes-
thetics or who had a penile hypersensitivity. Urologist an-
swered that 56% of PE patients were satisfied after SDN. 
Only 3.4% of the PE patients were dissatisfied with it. 
Although recurrence was observed in 10% of the patients, 
other complications were very rare.
　However, unfortunately, a standard procedure for SDN 
does not exist. The location of resection and the number of 
resected dorsal nerves varied among individual urologists. 
The cost of the procedure varied as well. SDN was more 
common in private clinics than in hospitals. Hospital urol-
ogists, particularly in teaching hospitals, had less interest 
in SDN. Therefore, a well-designed study should be con-
ducted considering both private and hospital urologists.
　Through this nationwide survey, we understood how 
contemporary urologists in Korea manage patients with 
PE. Korean urologists believe that subjective symptoms 
such as interpersonal difficulties and inability to control 
ejaculation are important along with definitive IELT for the 
diagnosis of PE. They have many treatment modalities and 
commonly perform SDN. However, studies or references 
in support of SDN are lacking. Further studies are required 
to establish effective treatment options for PE, including 
surgical treatment.
CONCLUSIONS
　A majority of Korean urologists diagnose PE by a multi-
dimensional approach using various diagnostic tools. 
Most urologists believe that medical treatment with SSRI is 
effective in the management of PE. At the same time, surgi-
cal treatment such as SDN also investigated as one of ma-
jor treatment modality despite the lack of scientific 
evidence.
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